Poster Presentations

R.K. Biswas, S. Ravi INDIA
Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion:
A prospective study

D. Branisteanu, C. Flondor, M. Gavril ROMANIA
Intravitreal bevacizumab for choroidal neovascularization secondary to pathologic myopia

J.L. Edelman, A. Nehme, E. Lobenhofer, D. Stamer USA
Clinically-relevant intravitreal corticosteroids generate unique pharmacologic responses in human trabecular meshwork

J. Edelman, A. Nehme USA
Is more better? Clinically-relevant high doses of dexamethasone inhibit a broad spectrum of cytokines secreted from inflamed retinal microvascular pericytes

M. Falcao, E. Brandao, F. Falcao-Reis, A. Carneiro PORTUGAL
Intravitreal anti-VEGF therapy for choroidal neovascularization secondary to angioid streaks: Short-term results

R. Halfeld Furtado De Mendonça, L. Principe, S. Abbruzzese, M. Centola, C. Bonaventura,
E. Rispoli ITALY
Using the full-field electroretinogram to detect retinal toxicity of vigabatrin

B. Kuppermann, A. Pirouzmanesh, A. Sharma, U.P. Andley, M.C. Kenney USA
Comparing the toxicity of triamcinolone acetonide and dexamethasone on human lens epithelial cells in vitro

G. Leon Salvatierra, A. Gonzalez Garrido, J. Garcia Sanchez, I. Gregori Gisbert, E. Mengual Verdu, J.R. Hueso Abancens SPAIN
Intravitreal bevacizumab in a patient with Best disease

I. Mantel SWITZERLAND
Ranibizumab for non-proliferative idiopathic juxtafoveolar retinal telangiectasis of group 2a

M. Neves, N. Lopes, R. Andrês, A. Barbosa PORTUGAL
Photodynamic therapy and chronic central serous chorioretinopathy: Two case reports

M. Nita, W. Romaniuk, A. Krasowska POLAND
Intravitreal injections of bevacizumab (Avastin®) in diseases other than AMD

E. Yaman Pinarci, B. Demirel, H. Gungel, G. Yilmaz, Y. Akova TURKEY
Combined treatment of intravitreal injection of bevacizumab (Avastin) and laser photocoagulation in von Hippel-Lindau disease